Literature DB >> 30916879

Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients.

Arnaud G L'Huillier1, Victor H Ferreira1, Terrance Ku1, Ilona Bahinskaya1, Deepali Kumar1, Atul Humar1.   

Abstract

Cytomegalovirus (CMV) is an immunomodulatory virus that indirectly increases the risk for bacterial, fungal, and viral infections. However, the pathogenesis of this phenomenon is poorly understood. We determined whether inflammatory responses to different Toll-like receptor (TLR) ligands are blunted during CMV infection in solid-organ transplant (SOT) patients. Peripheral blood mononuclear cells from 38 SOT patients with and without CMV were incubated in the presence of various viral, fungal, and bacterial TLR ligands. Cytokines were measured in the supernatant by multiplex enzyme-linked immunosorbent assay. Patients had blunted cytokine responses to bacterial, fungal, and viral ligands during CMV infection when compared to the absence of CMV infection. This was independent of viral load, clinical presentation of CMV infection or immunosuppression, supporting the clinical observation in SOT recipients that CMV infection increases susceptibility to bacterial, fungal, and other viral infections. Moreover, in the absence of CMV infection, patients with subsequent CMV infection had lower cytokines in response to TLR ligands compared to those without subsequent CMV infection, suggesting that inherent differences in patients not directly related to CMV also contribute to this increased susceptibility. In summary, these data provide novel ex vivo evidence to support indirect effects of CMV.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  cellular biology; complication: infectious; cytokines/cytokine receptors; immunobiology; infection and infectious agents - viral: Cytomegalovirus (CMV); infectious disease; innate immunity; translational research/science

Year:  2019        PMID: 30916879     DOI: 10.1111/ajt.15371

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

Review 1.  Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.

Authors:  Ajit P Limaye; Tara M Babu; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2020-10-28       Impact factor: 26.132

2. 

Authors:  Kelli Li; Abid Khan; Sharmistha Mishra; Alice Zhabokritsky
Journal:  CMAJ       Date:  2021-04-19       Impact factor: 8.262

3.  Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients.

Authors:  Richard Ahn; Joanna Schaenman; Zachary Qian; Harry Pickering; Victoria Groysberg; Maura Rossetti; Megan Llamas; Alexander Hoffmann; David Gjertson; Mario Deng; Suphamai Bunnapradist; Elaine F Reed
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

4.  Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication.

Authors:  Isabel Rodríguez-Goncer; María Ruiz-Ruigómez; Francisco López-Medrano; Hernando Trujillo; Esther González; Natalia Polanco; Eduardo Gutiérrez; Rafael San Juan; Laura Corbella; Tamara Ruiz-Merlo; Patricia Parra; María Dolores Folgueira; Amado Andrés; José María Aguado; Mario Fernández-Ruiz
Journal:  Transpl Int       Date:  2022-01-20       Impact factor: 3.782

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.